Skip to main content

Table 1 Number of staff questionnaires (Q), focus group discussions (FGD) and chart reviews by country/hospital site

From: Usefulness and applicability of the revised dengue case classification by disease: multi-centre study in 18 countries

Country N Staff Q N FGDs Chart Reviews
    N (m/f*) Prospective review (% of all charts)** Mean age (SD) laboratory-confirmed
India 54 7 148 (106/42) 0 29 (14.4) 146 (99%)
Indonesia 115 6 389 (207/182) 303 (78%) 16 (10.8) 98 (25%)
Malaysia 92 5 353 (233/120) 336 (95%) 26 (14.4) 234 (66%)
Philippines 101 18 347 (174/173) 337 (97%) 14 (9.0) 0 (0)
Singapore 0 0 103 (60/43) 0 40 (14.2) 103(100%)
Saudi Arabia 187 6 299 (164/35) 179 (90%) 31 (13.0) 174 (87%)
Asia subtotal 549 42 1539 (944/959) 1155 (75%) 23 (14.6) 755 (49%)
Bolivia 137 5 256 (115/141) 194 (76%) 23 (15.3) 142 (55)
Brazil 0 0 94 (46/48) 0 37 (18.6) 93 (99)
Colombia 21 0 141 (68/73) 76 (54%) 14 (16.0) 59 (42)
Cuba 38 3 100 (39/61) 0 26 (19.3) 98 (98)
El Salvador 90 3 60 (30/30) 60 (100%) 8 (6.1) 56 (93)
Ecuador 70 4 72 (42/30) 54 (75%) 24 (18.9) 60 (83)
Mexico 58 0 38 (22/16) 38 (100%) 34 (19.2) 21 (55)
Nicaragua 108 2 528 (267/261) 346 (66%) 9 (6.9) 475 (90)
Paraguay 111 3 92 (36/56) 13 (14%) 36 (19.2) 46 (50)
Peru 80 0 117 (63/54) 39 (33%) 26 (16.4) 21 (18)
Puerto Rico 9 4 58 (30/28) 42 (72%) 27 (19.1) 31 (53)
Venezuela 17 5 153 (75/78) 75 (49%) 12 (11.3) 12 (8)
Latin America subtotal 739 29 1709 (833/876) 937 (55%) 19 (17.0) 1114 (65%)
Grand Total 1288 71 3248 (1777/1471) 2092 (64%) 21 (16.0) 1869 (58%)
  1. * m/f: male/female ratio; ** all charts include retrospective and prospective reviews